Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2004
05/06/2004US20040087626 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
05/06/2004US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides
05/06/2004US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases
05/06/2004US20040087623 Pyrazole derivatives against tgf overexpression
05/06/2004US20040087619 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
05/06/2004US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands
05/06/2004US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists
05/06/2004US20040087570 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
05/06/2004US20040087547 Orally administered antitumor agents
05/06/2004US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide
05/06/2004US20040084660 Exhibit a wide range of color, i.e., from pink to purple to blue gray, upon activation by a source of UV light and that, when the irradiation is discontinued, the original color is recovered
05/06/2004EP1415990A1 Diazepan derivatives useful as factor X inhibitor
05/06/2004EP1415987A1 Nitrogenous aromatic ring compounds
05/06/2004EP1414817A1 Substituted isoindoles and e use thereof
05/06/2004EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides
05/06/2004EP1414808A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
05/06/2004EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology
05/06/2004EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
05/06/2004EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
05/06/2004EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
05/06/2004EP1414775A2 Novel bicyclic and tricyclic cannabinoids
05/06/2004EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
05/06/2004EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
05/06/2004EP1305307B1 Indole derivatives useful for the treatment of cns disorders
05/06/2004EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
05/06/2004EP1163237B1 Amide derivatives
05/06/2004EP1036072B1 Thrombin receptor antagonists
05/06/2004EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
05/06/2004DE10248876A1 Production of aromatic oligomers, e.g. semiconductors in field-effect transistors and organic luminescent diodes, comprises coupling of an aromatic lithium compound in presence of copper(II) compound
05/06/2004CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
05/06/2004CA2503280A1 Allyloxy and allylsulfanyl compounds and use thereof as ppar modulators
05/06/2004CA2503276A1 Novel compounds useful in treating ppar mediated diseases
05/06/2004CA2503015A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/06/2004CA2502478A1 1-phenylpyrrolidine-2-one-3-carboxamides
05/06/2004CA2498215A1 Oxindole substituted piperazine derivatives
05/05/2004CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
05/05/2004CN1494543A Substituted benzofuran-2-carboxamides derivatives
05/05/2004CN1494539A Antagonists of MCP-1 function and methods of use thereof
05/05/2004CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
05/05/2004CN1494530A Heterocyclic diamide invertebrate pest control agents
05/05/2004CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
05/05/2004CN1148356C Benzosulfone derivatives
05/05/2004CN1148351C Compound for curing vascular complication, its preparing method and treating use
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730792 β3 adrenergic agonists
05/04/2004US6730782 Carbamoyl substituted β-lactams
05/04/2004US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
05/04/2004US6730670 7-phenyl-benzo[b]thiophen amide derivatives
04/2004
04/29/2004WO2004035571A1 Substituted indoles and their use as hcv inhibitors
04/29/2004WO2004035570A1 Large conductance calcium-activated k channel opener
04/29/2004WO2004035560A1 Pyrrole derivative, intermediate, and agricultural or horticultural bactericide
04/29/2004WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
04/29/2004WO2004035544A1 Benzo[d]azepine derivatives for the treatment of neurological and psychiatric disorders
04/29/2004WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists
04/29/2004WO2004035039A1 Heterocyclic amides and their use in treating thromboembolic diseases and tumors
04/29/2004WO2004022712A3 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
04/29/2004WO2004016086A3 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
04/29/2004WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
04/29/2004WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions
04/29/2004WO2004000230A3 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
04/29/2004WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
04/29/2004WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
04/29/2004US20040082786 Piperazine based inhibitors of factor xa
04/29/2004US20040082785 Process for making an aldehyde
04/29/2004US20040082780 Vanilloid receptor ligands and their use in treatments
04/29/2004US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof
04/29/2004US20040082647 Anticholesterol agents; controlling bile acid transfer into intestines
04/29/2004US20040082638 Compounds, compositions and methods
04/29/2004US20040082635 Fused cyclic compounds and medicinal use thereof
04/29/2004US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/29/2004US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
04/29/2004US20040082611 Novel sulfonyl derivatives
04/29/2004US20040082610 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
04/29/2004US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases
04/29/2004US20040082601 Anti-inflammatory compounds
04/29/2004US20040082592 Metabotropic glutamate receptor antagonists
04/29/2004US20040082590 Dietetics; antidiabetic agents; sexual disorders
04/29/2004US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders
04/29/2004US20040082583 Chemical compounds
04/29/2004US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor
04/29/2004US20040082572 Benzodiazepine derivatives as app modulators
04/29/2004US20040082571 Substituted piperazines
04/29/2004US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
04/29/2004CA2501979A1 Large conductance calcium-activated k channel opener
04/29/2004CA2501706A1 Heterocyclic amides and the use thereof in the treatment of thromboembolic diseases and tumors
04/29/2004CA2501547A1 Substituted indoles and their use as hcv inhibitors
04/29/2004CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
04/29/2004CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists
04/28/2004EP1413580A1 Furanone derivatives as inhibitors of Cathepsin S
04/28/2004EP1413579A1 Imidazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing them
04/28/2004EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
04/28/2004EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists
04/28/2004EP1413305A1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
04/28/2004EP1412364A1 Platelet adp receptor inhibitors
04/28/2004EP1412355A1 New pyrazolo(3,4-d)pyrimidines inhibiting h. pylori infections
04/28/2004EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
04/28/2004EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres
04/28/2004EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
04/28/2004EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity
04/28/2004EP1412327A2 Inhibitors of protein kinase for the treatment of disease